Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Professional Topics

Subcategories:AwardsCareer DevelopmentEthicsInterprofessional PerspectiveLegislation & AdvocacyPresident's PerspectiveProfilesRheuminations

Drug Diversion Concerns on the Rise

Kurt Ullman  |  September 5, 2012

Medications removed from legitimate supply channels can affect both physician and patient.

Ethics Forum: The Ethical Side of End-of-Life Decisions

C. Ronald MacKenzie, MD  |  September 5, 2012

The role of the consulting physicians in the ICU, the concept of medical futility, and the management of complex patients when the goals of care may be changing.

Extended Warranties for Medical Equipment

Steven M. Harris, Esq.  |  September 5, 2012

The art of purchasing a piece of medical equipment requires the perfect combination of medical, financial, business, and legal expertise.

Partners in Advancing Rheumatology

James O’Dell, MD, and David I. Daikh, MD, PhD  |  August 8, 2012

The REF is making great strides in advancing treatment and finding cures for rheumatic disease.

Rheumatology Students Learning How To Look for Symptoms

Simon M. Helfgott, MD  |  August 8, 2012

First impressions and presumptions can lead us astray if we don’t pay attention.

The American Board of Bada Bing

Bruce N. Cronstein, MD  |  August 8, 2012

CME, recertification—what really gets quality results?

AMA House of Delegates Meeting: Decisions Affecting You

Gary Bryant, MD  |  August 8, 2012

An overview of some of the issues that were covered during the June 2012 American Medical Association House of Delegates meeting to debate policy.

Outstanding ARHP Program Planned for the ACR/ARHP Annual Meeting

Afton L. Hassett, PsyD  |  August 8, 2012

The primary tracks at the meeting will focus on clinical practice, clinical science, basic science, and business/administration; four subtracks will include sessions relevant for educators, those interested in pediatrics, practice managers, and rheumatology trainees.

Care of Rheumatologist Leads Patient to Give Back

Staff  |  August 8, 2012

After his rheumatologist helped him get back on his feet, Craig Plumhoff got involved with the ACR Research and Education Foundation to help others like him.

American College of Rheumatology Leads Charge to Address Excessive Patient Cost Sharing

Staff  |  August 8, 2012

The ACR Government Affairs Committee has developed legislative language to limit commercial insurance plans’ cost-sharing requirements for medications in a specialty drug tier to the dollar amount applicable to drugs in the nonpreferred-brand drug tier.

  • « Previous Page
  • 1
  • …
  • 121
  • 122
  • 123
  • 124
  • 125
  • …
  • 153
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences